Figure 3

Practice patterns and outcomes of repository corticotropin injection (Acthar® Gel) use in childhood nephrotic syndrome: A study of the North American Pediatric Renal Trials and collaborative studies and the Pediatric Nephrology Research Consortium

Mohammed K Faizan*, Courtney McCracken, Kenneth Lieberman, Traci Leong and Mark R Benfield

Published: 23 July, 2021 | Volume 5 - Issue 2 | Pages: 067-076

Response to Acthar Gel among 37 pediatric patients with active nephrotic syndrome at start of treatment by disease histology.

" alt="jcn-aid1077-g003"class="img-responsive img-rounded " style="cursor:pointer">

Figure 3:

Response to Acthar Gel among 37 pediatric patients with active nephrotic syndrome at start of treatment by disease histology.

Read Full Article HTML DOI: 10.29328/journal.jcn.1001077 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?